{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-22-000107","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2022-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.358104+00:00","generated_at":"2026-06-25T01:50:15.208095+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quest Diagnostics names Sam Samad as EVP & CFO, effective July 25, 2022","bullets":["Samad joins from Illumina (CFO since 2017); start date July 11, CFO role effective July 25.","Base salary $650k; target annual incentive 90% of base; initial equity grant $2.5M (50% performance shares, 25% options, 25% RSUs).","Sign-on inducement: cash payment of $1.2M (refundable if voluntary exit within 2 years) and RSUs valued at $1.5M vesting over 2 years.","Outgoing CFO Mark Guinan remains through Q2 earnings report for transition.","Samad eligible for executive severance plan, relocation benefits up to $105k, and share ownership guideline of 4x base salary."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-22-000107","json":"https://secwatch.observer/filing/0001022079-22-000107.json","markdown":"https://secwatch.observer/filing/0001022079-22-000107.md","text":"https://secwatch.observer/filing/0001022079-22-000107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/dgx-20220608.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:50:15.208095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ef7cba10b","claim":"Sam Samad was appointed as Executive Vice President and Chief Financial Officer at QUEST DIAGNOSTICS INC.","evidence_excerpt":"On June 9, 2022, Quest Diagnostics Incorporated (the “Company”) announced that Sam Samad will become Executive Vice President and Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"c07346ffe4","claim":"Mark Guinan departed as Chief Financial Officer at QUEST DIAGNOSTICS INC.","evidence_excerpt":"Mr. Samad succeeds Mark Guinan, who, in February 2022, announced his decision to retire.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"announced retirement"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}